June 8, 2022
FDA: Class I recall of Philips Respironics V60, V60 Plus Ventilators
Editor's Note
The Food and Drug Administration on June 3 identified the recall by Philips Respironics of all V60 and V60 Plus Ventilators as Class I, the most serious.
The recall was initiated because an internal power fluctuation may cause the ventilator to shut down unintentionally with or without any visible or audible alarms. Such failures may lead to patients being deprived of oxygen for an extended time.
As of April 14, there have been 4 injuries and 1 death reported. Distribution dates were May 1, 2009, to December 22, 2021.
Free Daily News
- Study: Cataract surgery increases diabetic retinopathy progression
- FDA announces Class 1 endovascular system, anesthesia system recalls
- Cost-shifting concerns rise as GOP eyes Medicaid cuts
- Study: Prolonged general anesthesia linked to long-term cognitive decline
- Real-time cancer detection improves brain surgery precision
- Research highlights anesthesia provider knowledge gap on drug, hormonal contraceptive interactions
- Healthcare CFOs prioritize cost control, data-driven decisions
- Study links intraoperative synthetic opioids, worse postoperative pain
- Tooth-in-eye surgery offers hope for restored vision
- Tenet Healthcare's strategic ASC expansion, hospital divestitures boost 2024 Q4 results
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement